These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15612337)

  • 21. Experts' agency problems: evidence from the prescription drug market in Japan.
    Iizuka T
    Rand J Econ; 2007; 38(3):844-62. PubMed ID: 18478669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variations in activity and practice patterns: a French study for GPs.
    Béjean S; Peyron C; Urbinelli R
    Eur J Health Econ; 2007 Sep; 8(3):225-36. PubMed ID: 17279404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of pharmacy benefit design on patient-physician communication about costs.
    Shrank WH; Fox SA; Kirk A; Ettner SL; Cantrell CH; Glassman P; Asch SM
    J Gen Intern Med; 2006 Apr; 21(4):334-9. PubMed ID: 16686808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practice-level effects of interventions to improve asthma care in primary care settings: the Pediatric Asthma Care Patient Outcomes Research Team.
    Finkelstein JA; Lozano P; Fuhlbrigge AL; Carey VJ; Inui TS; Soumerai SB; Sullivan SD; Wagner EH; Weiss ST; Weiss KB;
    Health Serv Res; 2005 Dec; 40(6 Pt 1):1737-57. PubMed ID: 16336546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disparities in asthma medication dispensing patterns: the case of pediatric asthma in Puerto Rico.
    Vila D; Rand CS; Cabana MD; Quiñones A; Otero M; Gamache C; Ramírez R; García P; Canino G
    J Asthma; 2010 Dec; 47(10):1136-41. PubMed ID: 21039213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence.
    Lexchin J; Grootendorst P
    Int J Health Serv; 2004; 34(1):101-22. PubMed ID: 15088676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Out-of-pocket medication costs and use of medications and health care services among children with asthma.
    Karaca-Mandic P; Jena AB; Joyce GF; Goldman DP
    JAMA; 2012 Mar; 307(12):1284-91. PubMed ID: 22453569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic Health Outcomes and Prescription Drug Copayments in Medicaid.
    Kostova D; Fox J
    Med Care; 2017 May; 55(5):520-527. PubMed ID: 28234755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic disease medication use in managed care and indemnity insurance plans.
    Stafford RS; Davidson SM; Davidson H; Miracle-McMahill H; Crawford SL; Blumenthal D
    Health Serv Res; 2003 Apr; 38(2):595-612. PubMed ID: 12785563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medication prescribing advice and drug utilization: a review from the United Kingdom.
    Law J; Thompson A
    Pharm Pract Manag Q; 1996 Jan; 15(4):27-35. PubMed ID: 10153842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergency hospital admissions after income-based deductibles and prescription copayments in older users of inhaled medications.
    Dormuth CR; Maclure M; Glynn RJ; Neumann P; Brookhart AM; Schneeweiss S
    Clin Ther; 2008; 30 Spec No(Spec No):1038-50. PubMed ID: 18640478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada.
    Alan S; Crossley TF; Grootendorst P; Veall MR
    J Health Econ; 2002 Sep; 21(5):805-26. PubMed ID: 12349883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of copayments on drug use in the presence of annual payment limits.
    Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid population.
    Bae SJ; Paltiel AD; Fuhlbrigge AL; Weiss ST; Kuntz KM
    Value Health; 2008; 11(1):110-8. PubMed ID: 18237365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of switching to a high-deductible health plan on use of chronic medications.
    Reiss SK; Ross-Degnan D; Zhang F; Soumerai SB; Zaslavsky AM; Wharam JF
    Health Serv Res; 2011 Oct; 46(5):1382-401. PubMed ID: 21413983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between physician financial incentives and the prescribing of anti-asthmatic medications in children in US outpatient settings.
    Chang J; Freed GL; Prosser LA; Patel I; Erickson SR; Bagozzi RP; Balkrishnan R
    J Child Health Care; 2013 Jun; 17(2):125-37. PubMed ID: 23424001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of cholesterol-lowering medications in the United States from 1991 to 1997.
    Siegel D; Lopez J; Meier J
    Am J Med; 2000 Apr; 108(6):496-9. PubMed ID: 10781783
    [No Abstract]   [Full Text] [Related]  

  • 38. Beyond survey data: a claims-based analysis of drug use and spending by the elderly.
    Steinberg EP; Gutierrez B; Momani A; Boscarino JA; Neuman P; Deverka P
    Health Aff (Millwood); 2000; 19(2):198-211. PubMed ID: 10718034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physicians' prescribing responses to a restricted formulary: the impact of Medicaid preferred drug lists in Illinois and Louisiana.
    Virabhak S; Shinogle JA
    Am J Manag Care; 2005 Jan; 11 Spec No():SP14-20. PubMed ID: 15700905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing the medical homes model for children with asthma.
    Domino ME; Humble C; Lawrence WW; Wegner S
    Med Care; 2009 Nov; 47(11):1113-20. PubMed ID: 19786921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.